MedBioSphere
Articles Videos The Web  
    

Ranbaxy and AstraZeneca Reach Agreement

Selected Abstract

Ranbaxy and AstraZeneca Reach Agreement in Esomeprazole Patent Litigation.
Companies Also Sign Manufacturing and Distribution Agreement GURGAON, India and PRINCETON, N.J., April 15 /PRNewswire/ -- Ranbaxy Pharmaceuticals Inc. (RPI), a wholly owned subsidiary of Ranbaxy Laboratories Limited (RLL), announced today that it has reached several agreements with AstraZeneca. Two ...
April 15, 2008; PR Newswire

Read the full article with a free-trial membership at HighBeam Research



Related Articles

1. Ranbaxy and AstraZeneca Reach Agreement in Esomeprazole Patent Litigation.